资讯

Capably Raises $4M to Replace Legacy Automation and Lead the Next Wave of Agentic AI ...
Capably, the Intelligent Automation platform, has raised $4 million to help businesses effortlessly delegate work to AI ...
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First ...
Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...